Volume 14 Issue 1
MYELOID TUMORS |
|
---|---|
Factors for Sustaining Molecular Remission after Discontinuation of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia: Results of Non-Randomized Prospective Clinical TrialShukhov OA, Petrova AN, Chelysheva EYu, Bykova AV, Nemchenko IS, Turkina AG |
PDF |
Identification of Mutations in IDH1/2, DNMT3A, ASXL1 Genes of Genome Epigenetic Regulation and Their Co-Occurrence with FLT3, NPM1, RUNX1 Mutations in Acute Myeloid LeukemiaBelotserkovskaya EV, Zaikova EK, Petukhov AV, Demidov ON, Levchuk KA, Budaeva IG, Zaitsev DV, Rogovaya YuD, Shatilova AA, Bogdanov KV, Mirolyubova YuV, Nikulina TS, Zaritskey AYu, Girshova LL |
PDF |
Comparative Analysis of Myelofibrosis Treatment Outcomes with the Use of Ruxolitinib Versus Ruxolitinib with Subsequent Allogeneic Hematopoietic Stem Cell TransplantationBarabanshchikova MV, Morozova EV, Vlasova YuYu, Gindina TL, Evdokimov AV, Barkhatov IM, Baikov VV, Ivanova IO, Rudakova TA, Bakin EA, Moiseev IS, Kulagin AD |
PDF |
Gynecological Myeloid Sarcoma: Literature Review and a Case ReportShatilova AA, Girshova LL, Zaitsev DV, Budaeva IG, Mirolyubova YuV, Ryzhkova DV, Grozov RV, Bogdanov KV, Nikulina TS, Motorin DV, Zammoeva DB, Efremova SV, Ivanov VV, Petukhov AV, Alekseeva YuA, Zaritskey AYu |
PDF |
Ph-Negative Myeloproliferative Neoplasms: Diagnosis and Treatment Challenges in Russia (the Case of Saint Petersburg)Ivanova MO, Morozova EV, Barabanshchikova MV, Afanasyev BV |
PDF |
LYMPHOID TUMORS |
|
Checkpoint Inhibitors and Classical Hodgkin’s Lymphoma: Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Tumor (Experience at the NI Pirogov Russian National Medical Center of Surgery)Sarzhevskii VO, Demina EA, Mochkin NE, Spornik AA, Mamedova AA, Smirnova EG, Bannikova AE, Samoilova AA, Bogatyrev VS, Melnichenko VYa |
PDF |
Hodgkin’s Lymphoma in HIV-Infected PatientsPivnik AV, Vukovich AM, Kremneva NV, Dubnitskaya MG, Tsakhilova AV |
PDF |
Chronic Lymphocytic Leukemia in Blood Relatives: Two Case Reports of Male SiblingsKurkina NV, Repina EA |
PDF |
BONE MARROW TRANSPLANTATION |
|
Retrospective Survival Analysis of Multiple Myeloma Patients after Autologous Hematopoietic Stem Cell TransplantationKostroma II, Zhernyakova AA, Zapreeva IM, Sidorova ZhYu, Semenova NYu, Karyagina EV, Stepchenkova EI, Bessmeltsev SS, Chechetkin AV, Gritsaev SV |
PDF |
RARE NON-NEOPLASTIC TUMORS AND SYNDROMES |
|
Comparative Pathomorphology of Lymph Node Changes in Kikuchi-Fujimoto and Autoimmune Diseases with Lymphadenopathy: Own ExperienceKovrigina AM |
PDF |
COMPLICATIONS OF ONCOHEMATOLOGICAL DISEASES |
|
Organ Lesions in Adults with Secondary Hemophagocytic SyndromePotapenko VG, Klimovich AV, Avdoshina DD, Baikov VV, Vinogradova NV, Goloshchapov OV, Doguzhieva EV, Zinina EE, Kachenya GV, Krivolapov YuA, Karyagina EV, Kulibaba TG, Lapin SV, Leenman EE, Pavlyuchenko ES, Potikhonova NA, Pervakova MYu, Popova NB, Rysev AV, Ryabchikova VV, Surkova EA, Fedunyak IP, Medvedeva NV |
PDF |
REVIEWS |
|
EVI1-Positive Leukemias and Myelodysplastic Syndromes: Theoretical and Clinical Aspects (Literature Review)Mamaev NN, Shakirova AI, Morozova EV, Gindina TL |
PDF |
Opportunities of Chronic Myeloid Leukemia Treatment with Reduced Doses of Tyrosine Kinase InhibitorsGuryanova MA, Chelysheva EYu, Turkina AG |
PDF |
Current View on Diagnosis and Treatment of Classical Ph-Negative Myeloproliferative NeoplasmsMelikyan AL, Subortseva IN, Shuvaev VA, Lomaia EG, Morozova EV, Kuzmina LA, Vinogradova OYu, Zaritskey AYu |
PDF |
CAR T-Cell Therapy with NKG2D Chimeric Antigen Receptor in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic SyndromeLevchuk KA, Belotserkovskaya EV, Pozdnyakov DYu, Girshova LL, Zaritskey AYu, Petukhov AV |
PDF |
CAR-T Technology and New Opportunities for Tumor TreatmentPavlova VYu, Livadnyi ES |
PDF |